2 results
Approved WMOCompleted
To determine the specificity of the effects of histamine H1-receptor blockade on different cognitive functions and processes.
Approved WMOCompleted
To compare pembrolizumab plus lenvatinib in combination with TACE versus placebo plus TACE with regard to progression-free survival (PFS) per RECIST 1.1 assessed by blinded, independent central review (BICR)